Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of TY-302 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients
- Status
- COMPLETED
- Phase
- NA
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study of ASN004 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
SOFT- Stereotactic Ablative Radiotherapy of Infra-diaphragmatic Soft Tissue Metastases
- Status
- UNKNOWN
- Phase
- NA
Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ONO-7913 Phase I Study (ONO-7913)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy
- Status
- TERMINATED
- Phase
- PHASE2
OH2 Injection in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Study in Advanced Malignancies With 5-ALA
- Status
- SUSPENDED
- Phase
- PHASE1
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Effect of PARP Inhibitors on Glomerular Filtration Rate
- Status
- TERMINATED
- Phase
- N/A